Cargando…
MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2
BACKGROUND: Chemotherapy based on paclitaxel (PTX) is the standard treatment for a range of cancers, including triple-negative breast cancer (TNBC), but the increasing development of resistance has reduced/has negatively impacted its clinical utility. A previous study demonstrated that miR-5195-3p c...
Autores principales: | Liu, Mei, Gong, Can, Xu, Renyuan, Chen, Yu, Wang, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604428/ https://www.ncbi.nlm.nih.gov/pubmed/31308851 http://dx.doi.org/10.1186/s11658-019-0168-7 |
Ejemplares similares
-
MicroRNA-34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel
por: Yanokura, Megumi, et al.
Publicado: (2020) -
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016) -
Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
por: Xu, Zhiyuan, et al.
Publicado: (2019) -
MicroRNA-5195-3p alleviates high glucose‑induced injury in human ARPE-19 cells by targeting GMFB
por: Liu, Jingjing, et al.
Publicado: (2021) -
MicroRNA‐433‐3p enhances chemosensitivity of glioma to cisplatin by downregulating NR5A2
por: Li, Jun, et al.
Publicado: (2022)